BEIJING--(BUSINESS WIRE)--SAIF Partners IV L.P., (“SAIF Partners”), the largest single investor in Sinovac Biotech Ltd. (“Sinovac” or the “Company”), beneficially owning approximately 15% of the ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Recent headlines about a potent new immunotherapy have mostly focused on the U.S.

McCarthy’s experience and network will help identify early-stage biotech companies developing sustainable solutions in agriculture, food, chemicals, and materials PARIS--(BUSINESS WIRE)--Sofinnova ...

Ori Biotech officials say the company has launched its Preferred Partner Network (PPN), bringing together academic medical centers (AMCs) and contract development and manufacturing organizations ...

(RTTNews) - Purple Biotech Ltd. (PPBT), a clinical-stage company focused on developing therapies for overcoming tumor immune evasion, on Monday announced a research collaboration with the Icahn School ...

Evaxion Biotech A/S (NASDAQ:EVAX) inked an option and licensing deal with Merck & Co., Inc (NYSE:MRK) for two preclinical vaccine candidates. Evaxion also granted Merck an option to license ...

Kaspar Hallsten, CIO and Portfolio Manager at Rhenman & Partners, built his analytical foundation at PricewaterhouseCoopers ...

Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the US biopharma ecosystem with Europe, today announced ...